><ref id="b1"><mixed-citation publication-type="other">World Health Organization. &#x0201c;Global tuberculosis report 2015.&#x0201d; 07/10/2015 (2015).</mixed-citation></ref><ref id="b2"><mixed-citation publication-type="journal"><name><surname>Lawn</surname><given-names>S. D.</given-names></name> &#x00026; <name><surname>Zumla</surname><given-names>A. I.</given-names></name>
<article-title>Tuberculosis</article-title>. <source>Lancet</source>
<volume>378</volume>, <fpage>57</fpage>&#x02013;<lpage>72</lpage>, doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(10)62173-3</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21420161</pub-id></mixed-citation></ref><ref id="b3"><mixed-citation publication-type="journal"><name><surname>Prabowo</surname><given-names>S. A.</given-names></name>
<etal/>. <article-title>Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines</article-title>. <source>Med Microbiol Immunol</source>
<volume>202</volume>, <fpage>95</fpage>&#x02013;<lpage>104</lpage>, doi: <pub-id pub-id-type="doi">10.1007/s00430-012-0278-6</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23143437</pub-id></mixed-citation></ref><ref id="b4"><mixed-citation publication-type="journal"><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name>
<article-title>Tuberculosis vaccines: time to think about the next generation</article-title>. <source>Semin Immunol</source>
<volume>25</volume>, <fpage>172</fpage>&#x02013;<lpage>181</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.smim.2013.04.006</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23706597</pub-id></mixed-citation></ref><ref id="b5"><mixed-citation publication-type="journal"><name><surname>Isaacs</surname><given-names>A.</given-names></name> &#x00026; <name><surname>Lindenmann</surname><given-names>J.</given-names></name>
<article-title>Virus interference. I. The interferon</article-title>. <source>Proc R Soc Lond B Biol Sci</source>
<volume>147</volume>, <fpage>258</fpage>&#x02013;<lpage>267</lpage> (<year>1957</year>).<pub-id pub-id-type="pmid">13465720</pub-id></mixed-citation></ref><ref id="b6"><mixed-citation publication-type="journal"><name><surname>Nagano</surname><given-names>Y.</given-names></name> &#x00026; <name><surname>Kojima</surname><given-names>Y.</given-names></name>
<article-title>[Inhibition of vaccinia infection by a liquid factor in tissues infected by homologous virus]</article-title>. <source>C R Seances Soc Biol Fil</source>
<volume>152</volume>, <fpage>1627</fpage>&#x02013;<lpage>1629</lpage> (<year>1958</year>).<pub-id pub-id-type="pmid">13639454</pub-id></mixed-citation></ref><ref id="b7"><mixed-citation publication-type="journal"><name><surname>Feld</surname><given-names>J. J.</given-names></name> &#x00026; <name><surname>Hoofnagle</surname><given-names>J. H.</given-names></name>
<article-title>Mechanism of action of interferon and ribavirin in treatment of hepatitis C</article-title>. <source>Nature</source>
<volume>436</volume>, <fpage>967</fpage>&#x02013;<lpage>972</lpage>, doi: <pub-id pub-id-type="doi">10.1038/nature04082</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">16107837</pub-id></mixed-citation></ref><ref id="b8"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>B. X.</given-names></name> &#x00026; <name><surname>Fish</surname><given-names>E. N.</given-names></name>
<article-title>The yin and yang of viruses and interferons</article-title>. <source>Trends Immunol</source>
<volume>33</volume>, <fpage>190</fpage>&#x02013;<lpage>197</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.it.2012.01.004</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22321608</pub-id></mixed-citation></ref><ref id="b9"><mixed-citation publication-type="journal"><name><surname>Chary</surname><given-names>A.</given-names></name> &#x00026; <name><surname>Holodniy</surname><given-names>M.</given-names></name>
<article-title>Interferon combination therapy for HIV/hepatitis C virus coinfection</article-title>. <source>Immunotherapy</source>
<volume>3</volume>, <fpage>1087</fpage>&#x02013;<lpage>1102</lpage>, doi: <pub-id pub-id-type="doi">10.2217/imt.11.105</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21913831</pub-id></mixed-citation></ref><ref id="b10"><mixed-citation publication-type="journal"><name><surname>Clark</surname><given-names>V.</given-names></name> &#x00026; <name><surname>Nelson</surname><given-names>D. R.</given-names></name>
<article-title>Novel interferons for treatment of hepatitis C virus</article-title>. <source>Clin Liver Dis</source>
<volume>13</volume>, <fpage>351</fpage>&#x02013;<lpage>363</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.cld.2009.05.004</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19628153</pub-id></mixed-citation></ref><ref id="b11"><mixed-citation publication-type="journal"><name><surname>Thitinan</surname><given-names>S.</given-names></name> &#x00026; <name><surname>McConville</surname><given-names>J. T.</given-names></name>
<article-title>Interferon alpha delivery systems for the treatment of hepatitis C</article-title>. <source>Int J Pharm</source>
<volume>369</volume>, <fpage>121</fpage>&#x02013;<lpage>135</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.ijpharm.2008.11.027</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19103271</pub-id></mixed-citation></ref><ref id="b12"><mixed-citation publication-type="journal"><name><surname>Heathcote</surname><given-names>J.</given-names></name>
<article-title>Consensus interferon: a novel interferon for the treatment of hepatitis C</article-title>. <source>J Viral Hepat</source>
<volume>5</volume> Suppl 1, <fpage>13</fpage>&#x02013;<lpage>18</lpage> (<year>1998</year>).</mixed-citation></ref><ref id="b13"><mixed-citation publication-type="journal"><name><surname>Trinchieri</surname><given-names>G. Type</given-names></name>
<article-title>I interferon: friend or foe?</article-title>
<source>J Exp Med</source>
<volume>207</volume>, <fpage>2053</fpage>&#x02013;<lpage>2063</lpage>, doi: <pub-id pub-id-type="doi">10.1084/jem.20101664</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20837696</pub-id></mixed-citation></ref><ref id="b14"><mixed-citation publication-type="journal"><name><surname>Pandey</surname><given-names>A. K.</given-names></name>
<etal/>. <article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source>
<volume>5</volume>, <fpage>e1000500</fpage>, doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1000500</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19578435</pub-id></mixed-citation></ref><ref id="b15"><mixed-citation publication-type="journal"><name><surname>Manca</surname><given-names>C.</given-names></name>
<etal/>. <article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>98</volume>, <fpage>5752</fpage>&#x02013;<lpage>5757</lpage>, doi: <pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id> (<year>2001</year>).<pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="b16"><mixed-citation publication-type="journal"><name><surname>Berry</surname><given-names>M. P.</given-names></name>
<etal/>. <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source>
<volume>466</volume>, <fpage>973</fpage>&#x02013;<lpage>977</lpage>, doi: <pub-id pub-id-type="doi">10.1038/nature09247</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="b17"><mixed-citation publication-type="journal"><name><surname>Koster</surname><given-names>R.</given-names></name>
<etal/>. <article-title>Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi&#x02019;s sarcoma cells by control of c-myc expression</article-title>. <source>Am J Pathol</source>
<volume>149</volume>, <fpage>1871</fpage>&#x02013;<lpage>1885</lpage> (<year>1996</year>).<pub-id pub-id-type="pmid">8952524</pub-id></mixed-citation></ref><ref id="b18"><mixed-citation publication-type="journal"><name><surname>Gong</surname><given-names>L.</given-names></name>, <name><surname>Devenish</surname><given-names>R. J.</given-names></name> &#x00026; <name><surname>Prescott</surname><given-names>M.</given-names></name>
<article-title>Autophagy as a macrophage response to bacterial infection</article-title>. <source>IUBMB Life</source>
<volume>64</volume>, <fpage>740</fpage>&#x02013;<lpage>747</lpage>, doi: <pub-id pub-id-type="doi">10.1002/iub.1070</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22815102</pub-id></mixed-citation></ref><ref id="b19"><mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>L.</given-names></name>, <name><surname>Munz</surname><given-names>C.</given-names></name> &#x00026; <name><surname>Lunemann</surname><given-names>J. D.</given-names></name>
<article-title>Autophagy-mediated antigen processing in CD4(+) T cell tolerance and immunity</article-title>. <source>FEBS Lett</source>
<volume>584</volume>, <fpage>1405</fpage>&#x02013;<lpage>1410</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.febslet.2010.01.008</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20074571</pub-id></mixed-citation></ref><ref id="b20"><mixed-citation publication-type="journal"><name><surname>Lunemann</surname><given-names>J. D.</given-names></name> &#x00026; <name><surname>Munz</surname><given-names>C.</given-names></name>
<article-title>Autophagy in CD4+ T-cell immunity and tolerance</article-title>. <source>Cell Death Differ</source>
<volume>16</volume>, <fpage>79</fpage>&#x02013;<lpage>86</lpage>, doi: <pub-id pub-id-type="doi">10.1038/cdd.2008.113</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">18636073</pub-id></mixed-citation></ref><ref id="b21"><mixed-citation publication-type="journal"><name><surname>Castillo</surname><given-names>E. F.</given-names></name>
<etal/>. <article-title>Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>109</volume>, <fpage>E3168</fpage>&#x02013;<lpage>3176</lpage>, doi: <pub-id pub-id-type="doi">10.1073/pnas.1210500109</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">23093667</pub-id></mixed-citation></ref><ref id="b22"><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>E. D.</given-names></name>, <name><surname>Chan</surname><given-names>J.</given-names></name> &#x00026; <name><surname>Schluger</surname><given-names>N. W.</given-names></name>
<article-title>What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge</article-title>. <source>Am J Respir Cell Mol Biol</source>
<volume>25</volume>, <fpage>606</fpage>&#x02013;<lpage>612</lpage>, doi: <pub-id pub-id-type="doi">10.1165/ajrcmb.25.5.4487</pub-id> (<year>2001</year>).<pub-id pub-id-type="pmid">11713103</pub-id></mixed-citation></ref><ref id="b23"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>N.</given-names></name>, <name><surname>Gowthaman</surname><given-names>U.</given-names></name>, <name><surname>Pahari</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Agrewala</surname><given-names>J. N.</given-names></name>
<article-title>Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!</article-title>
<source>PLoS Pathog</source>
<volume>8</volume>, <fpage>e1002676</fpage>, doi: 10.1371/journal.ppat.1002676 PPATHOGENS-D-11-02526 (<year>2012</year>).<pub-id pub-id-type="pmid">22719245</pub-id></mixed-citation></ref><ref id="b24"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>N.</given-names></name>, <name><surname>Vidyarthi</surname><given-names>A.</given-names></name>, <name><surname>Pahari</surname><given-names>S.</given-names></name> &#x00026; <name><surname>Agrewala</surname><given-names>J. N.</given-names></name>
<article-title>Distinct Strategies Employed by Dendritic Cells and Macrophages in Restricting <italic>Mycobacterium tuberculosis</italic> Infection: Different Philosophies but Same Desire</article-title>. <source>Int Rev Immunol</source>, doi: <pub-id pub-id-type="doi">10.3109/08830185.2015.1015718,</pub-id>[Epub ahead of print] (<year>2015</year>).</mixed-citation></ref><ref id="b25"><mixed-citation publication-type="journal"><name><surname>Fernando</surname><given-names>M. R.</given-names></name>, <name><surname>Reyes</surname><given-names>J. L.</given-names></name>, <name><surname>Iannuzzi</surname><given-names>J.</given-names></name>, <name><surname>Leung</surname><given-names>G.</given-names></name> &#x00026; <name><surname>McKay</surname><given-names>D. M.</given-names></name>
<article-title>The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e94188</fpage>, doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0094188</pub-id>PONE-D-14-04332 (<year>2014</year>).<pub-id pub-id-type="pmid">24736635</pub-id></mixed-citation></ref><ref id="b26"><mixed-citation publication-type="journal"><name><surname>van der Poll</surname><given-names>T.</given-names></name>
<etal/>. <article-title>Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia</article-title>. <source>J Infect Dis</source>
<volume>176</volume>, <fpage>439</fpage>&#x02013;<lpage>444</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9237710</pub-id></mixed-citation></ref><ref id="b27"><mixed-citation publication-type="journal"><name><surname>Godfrey</surname><given-names>K. R.</given-names></name>
<article-title>Chronopharmacology and its application to the development of theophylline treatment schedules for asthma</article-title>. <source>Eur J Clin Pharmacol</source>
<volume>36</volume>, <fpage>103</fpage>&#x02013;<lpage>109</lpage> (<year>1989</year>).<pub-id pub-id-type="pmid">2656270</pub-id></mixed-citation></ref><ref id="b28"><mixed-citation publication-type="journal"><name><surname>Nish</surname><given-names>S. A.</given-names></name>
<etal/>. <article-title>T cell-intrinsic role of IL-6 signaling in primary and memory responses</article-title>. <source>Elife</source>
<volume>3</volume>, <fpage>e01949</fpage>, doi: <pub-id pub-id-type="doi">10.7554/eLife.01949</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24842874</pub-id></mixed-citation></ref><ref id="b29"><mixed-citation publication-type="journal"><name><surname>Diehl</surname><given-names>S. A.</given-names></name>, <name><surname>Schmidlin</surname><given-names>H.</given-names></name>, <name><surname>Nagasawa</surname><given-names>M.</given-names></name>, <name><surname>Blom</surname><given-names>B.</given-names></name> &#x00026; <name><surname>Spits</surname><given-names>H.</given-names></name>
<article-title>IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells</article-title>. <source>Immunol Cell Biol</source>
<volume>90</volume>, <fpage>802</fpage>&#x02013;<lpage>811</lpage>, doi: <pub-id pub-id-type="doi">10.1038/icb.2012.17</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">22491065</pub-id></mixed-citation></ref><ref id="b30"><mixed-citation publication-type="journal"><name><surname>Saunders</surname><given-names>B. M.</given-names></name>, <name><surname>Frank</surname><given-names>A. A.</given-names></name>, <name><surname>Orme</surname><given-names>I. M.</given-names></name> &#x00026; <name><surname>Cooper</surname><given-names>A. M.</given-names></name>
<article-title>Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Infect Immun</source>
<volume>68</volume>, <fpage>3322</fpage>&#x02013;<lpage>3326</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">10816480</pub-id></mixed-citation></ref><ref id="b31"><mixed-citation publication-type="journal"><name><surname>Kropp</surname><given-names>K. A.</given-names></name>
<etal/>. <article-title>Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-gamma) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state</article-title>. <source>J Virol</source>
<volume>85</volume>, <fpage>10286</fpage>&#x02013;<lpage>10299</lpage>, doi: <pub-id pub-id-type="doi">10.1128/JVI.00373-11</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21775459</pub-id></mixed-citation></ref><ref id="b32"><mixed-citation publication-type="journal"><name><surname>Longhi</surname><given-names>M. P.</given-names></name>
<etal/>. <article-title>Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant</article-title>. <source>J Exp Med</source>
<volume>206</volume>, <fpage>1589</fpage>&#x02013;<lpage>1602</lpage>, doi: <pub-id pub-id-type="doi">10.1084/jem.20090247</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19564349</pub-id></mixed-citation></ref><ref id="b33"><mixed-citation publication-type="journal"><name><surname>Martinez</surname><given-names>J.</given-names></name>, <name><surname>Huang</surname><given-names>X.</given-names></name> &#x00026; <name><surname>Yang</surname><given-names>Y.</given-names></name>
<article-title>Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection <italic>in vivo</italic></article-title>. <source>J Immunol</source>
<volume>180</volume>, <fpage>1592</fpage>&#x02013;<lpage>1597</lpage>, doi: 180/3/1592 (<year>2008</year>).<pub-id pub-id-type="pmid">18209055</pub-id></mixed-citation></ref><ref id="b34"><mixed-citation publication-type="journal"><name><surname>Platanias</surname><given-names>L. C.</given-names></name>
<article-title>Mechanisms of type-I- and type-II-interferon-mediated signalling</article-title>. <source>Nat Rev Immunol</source>
<volume>5</volume>, <fpage>375</fpage>&#x02013;<lpage>386</lpage>, doi: <pub-id pub-id-type="doi">10.1038/nri1604</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">15864272</pub-id></mixed-citation></ref><ref id="b35"><mixed-citation publication-type="journal"><name><surname>Sakamoto</surname><given-names>E.</given-names></name>
<etal/>. <article-title>Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2</article-title>. <source>J Leukoc Biol</source>
<volume>78</volume>, <fpage>301</fpage>&#x02013;<lpage>309</lpage>, doi: <pub-id pub-id-type="doi">10.1189/jlb.1104690</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">15845643</pub-id></mixed-citation></ref><ref id="b36"><mixed-citation publication-type="journal"><name><surname>Guevara</surname><given-names>I.</given-names></name>
<etal/>. <article-title>Determination of nitrite/nitrate in human biological material by the simple Griess reaction</article-title>. <source>Clin Chim Acta</source>
<volume>274</volume>, <fpage>177</fpage>&#x02013;<lpage>188</lpage>, doi: S0009898198000606 (<year>1998</year>).<pub-id pub-id-type="pmid">9694586</pub-id></mixed-citation></ref><ref id="b37"><mixed-citation publication-type="journal"><name><surname>Yuk</surname><given-names>J. M.</given-names></name>
<etal/>. <article-title>Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin</article-title>. <source>Cell Host Microbe</source>
<volume>6</volume>, <fpage>231</fpage>&#x02013;<lpage>243</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.chom.2009.08.004</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19748465</pub-id></mixed-citation></ref><ref id="b38"><mixed-citation publication-type="journal"><name><surname>Caraglia</surname><given-names>M.</given-names></name>
<etal/>. <article-title>Alpha-interferon and its effects on signalling pathways within cells</article-title>. <source>Curr Protein Pept Sci</source>
<volume>5</volume>, <fpage>475</fpage>&#x02013;<lpage>485</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15581417</pub-id></mixed-citation></ref><ref id="b39"><mixed-citation publication-type="journal"><name><surname>Pfeffer</surname><given-names>L. M.</given-names></name>
<etal/>. <article-title>STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor</article-title>. <source>Science</source>
<volume>276</volume>, <fpage>1418</fpage>&#x02013;<lpage>1420</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9162009</pub-id></mixed-citation></ref><ref id="b40"><mixed-citation publication-type="journal"><name><surname>Stetson</surname><given-names>D. B.</given-names></name> &#x00026; <name><surname>Medzhitov</surname><given-names>R.</given-names></name>
<article-title>Type I interferons in host defense</article-title>. <source>Immunity</source>
<volume>25</volume>, <fpage>373</fpage>&#x02013;<lpage>381</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.007</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16979569</pub-id></mixed-citation></ref><ref id="b41"><mixed-citation publication-type="journal"><name><surname>Jahrling</surname><given-names>P. B.</given-names></name>
<etal/>. <article-title>Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections</article-title>. <source>J Infect Dis</source>
<volume>179</volume> Suppl 1, <fpage>S224</fpage>&#x02013;<lpage>234</lpage>, doi: <pub-id pub-id-type="doi">10.1086/514310</pub-id> (<year>1999</year>).<pub-id pub-id-type="pmid">9988188</pub-id></mixed-citation></ref><ref id="b42"><mixed-citation publication-type="journal"><name><surname>Julander</surname><given-names>J. G.</given-names></name>, <name><surname>Ennis</surname><given-names>J.</given-names></name>, <name><surname>Turner</surname><given-names>J.</given-names></name> &#x00026; <name><surname>Morrey</surname><given-names>J. D.</given-names></name>
<article-title>Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>55</volume>, <fpage>2067</fpage>&#x02013;<lpage>2073</lpage>, doi: <pub-id pub-id-type="doi">10.1128/AAC.01635-10</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21300837</pub-id></mixed-citation></ref><ref id="b43"><mixed-citation publication-type="journal"><name><surname>Brierley</surname><given-names>M. M.</given-names></name> &#x00026; <name><surname>Fish</surname><given-names>E. N.</given-names></name>
<article-title>Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry</article-title>. <source>J Interferon Cytokine Res</source>
<volume>22</volume>, <fpage>835</fpage>&#x02013;<lpage>845</lpage>, doi: <pub-id pub-id-type="doi">10.1089/107999002760274845</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">12396722</pub-id></mixed-citation></ref><ref id="b44"><mixed-citation publication-type="journal"><name><surname>Adah</surname><given-names>S. A.</given-names></name>, <name><surname>Bayly</surname><given-names>S. F.</given-names></name>, <name><surname>Cramer</surname><given-names>H.</given-names></name>, <name><surname>Silverman</surname><given-names>R. H.</given-names></name> &#x00026; <name><surname>Torrence</surname><given-names>P. F.</given-names></name>
<article-title>Chemistry and biochemistry of 2&#x02019;,5&#x02019;-oligoadenylate-based antisense strategy</article-title>. <source>Curr Med Chem</source>
<volume>8</volume>, <fpage>1189</fpage>&#x02013;<lpage>1212</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11472236</pub-id></mixed-citation></ref><ref id="b45"><mixed-citation publication-type="journal"><name><surname>Lande</surname><given-names>R.</given-names></name>
<etal/>. <article-title>IFN-alpha beta released by <italic>Mycobacterium tuberculosis</italic>-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells</article-title>. <source>J Immunol</source>
<volume>170</volume>, <fpage>1174</fpage>&#x02013;<lpage>1182</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12538673</pub-id></mixed-citation></ref><ref id="b46"><mixed-citation publication-type="journal"><name><surname>Fish</surname><given-names>E. N.</given-names></name>, <name><surname>Banerjee</surname><given-names>K.</given-names></name>, <name><surname>Levine</surname><given-names>H. L.</given-names></name> &#x00026; <name><surname>Stebbing</surname><given-names>N.</given-names></name>
<article-title>Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>30</volume>, <fpage>52</fpage>&#x02013;<lpage>56</lpage> (<year>1986</year>).<pub-id pub-id-type="pmid">3019238</pub-id></mixed-citation></ref><ref id="b47"><mixed-citation publication-type="journal"><name><surname>Desmet</surname><given-names>V. J.</given-names></name>, <name><surname>Knodell</surname><given-names>R. G.</given-names></name>
<etal/>. <article-title>Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431&#x02013;435]</article-title>. <source>J Hepatol</source>
<volume>38</volume>, <fpage>382</fpage>&#x02013;<lpage>386</lpage>, doi: S0168827803000059 (<year>2003</year>).<pub-id pub-id-type="pmid">12663226</pub-id></mixed-citation></ref><ref id="b48"><mixed-citation publication-type="journal"><name><surname>Alton</surname><given-names>K.</given-names></name>, <name><surname>Stabinsky</surname><given-names>Y.</given-names></name>, <name><surname>Richards</surname><given-names>R.</given-names></name>
<etal/>. <article-title>Production, characterization and biological effects of recombinant DNA derived human IFN-&#x003b1; and IFN-&#x003b2; analogs</article-title>. In: <name><surname>De Maeyer</surname><given-names>E.</given-names></name>, <name><surname>Schellekens</surname><given-names>H.</given-names></name> eds <source>The Biology of the Interferon System. Elsevier Science Publishers: Amsterdam</source>. <fpage>119</fpage>&#x02013;<lpage>128</lpage> (<year>1983</year>).</mixed-citation></ref><ref id="b49"><mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>A. M.</given-names></name>
<article-title>Cell-mediated immune responses in tuberculosis</article-title>. <source>Annu Rev Immunol</source>
<volume>27</volume>, <fpage>393</fpage>&#x02013;<lpage>422</lpage>, doi: <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132703</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19302046</pub-id></mixed-citation></ref><ref id="b50"><mixed-citation publication-type="journal"><name><surname>Everett</surname><given-names>H.</given-names></name> &#x00026; <name><surname>McFadden</surname><given-names>G.</given-names></name>
<article-title>Apoptosis: an innate immune response to virus infection</article-title>. <source>Trends Microbiol</source>
<volume>7</volume>, <fpage>160</fpage>&#x02013;<lpage>165</lpage>, doi: S0966-842X(99)01487-0 (<year>1999</year>).<pub-id pub-id-type="pmid">10217831</pub-id></mixed-citation></ref><ref id="b51"><mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>D. A.</given-names></name>, <name><surname>Klenerman</surname><given-names>P.</given-names></name>, <name><surname>Booth</surname><given-names>B. L.</given-names></name>, <name><surname>Phillips</surname><given-names>R. E.</given-names></name> &#x00026; <name><surname>Sewell</surname><given-names>A. K.</given-names></name>
<article-title>Cytotoxic T lymphocytes, chemokines and antiviral immunity</article-title>. <source>Immunol Today</source>
<volume>20</volume>, <fpage>212</fpage>&#x02013;<lpage>216</lpage>, doi: S0167-5699(99)01447-4 (<year>1999</year>).<pub-id pub-id-type="pmid">10322299</pub-id></mixed-citation></ref><ref id="b52"><mixed-citation publication-type="journal"><name><surname>Swanson</surname><given-names>C. L.</given-names></name>
<etal/>. <article-title>Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response</article-title>. <source>J Exp Med</source>
<volume>207</volume>, <fpage>1485</fpage>&#x02013;<lpage>1500</lpage>, doi: <pub-id pub-id-type="doi">10.1084/jem.20092695</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20566717</pub-id></mixed-citation></ref><ref id="b53"><mixed-citation publication-type="journal"><name><surname>Feld</surname><given-names>J.</given-names></name>
<etal/>. <article-title>Mechanism of action of interferon and ribavirin in treatment of hepatitis C</article-title>. <source>Nature</source>
<volume>436</volume>, <fpage>967</fpage>&#x02013;<lpage>972</lpage>, doi: <pub-id pub-id-type="doi">10.1038/nature04082</pub-id> (<year>2005</year>).<pub-id pub-id-type="pmid">16107837</pub-id></mixed-citation></ref><ref id="b54"><mixed-citation publication-type="journal"><name><surname>Heinrich</surname><given-names>P. C.</given-names></name>, <name><surname>Behrmann</surname><given-names>I.</given-names></name>, <name><surname>Muller-Newen</surname><given-names>G.</given-names></name>, <name><surname>Schaper</surname><given-names>F.</given-names></name> &#x00026; <name><surname>Graeve</surname><given-names>L.</given-names></name>
<article-title>Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway</article-title>. <source>Biochem J</source>
<volume>334</volume><bold>(Pt 2)</bold>, <fpage>297</fpage>&#x02013;<lpage>314</lpage> (<year>1998</year>).<pub-id pub-id-type="pmid">9716487</pub-id></mixed-citation></ref><ref id="b55"><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>H.</given-names></name>
<etal/>. <article-title>Nitric oxide induces apoptosis and autophagy; autophagy down-regulates NO synthesis in physalin A-treated A375-S2 human melanoma cells</article-title>. <source>Food Chem Toxicol</source>
<volume>71</volume>, <fpage>128</fpage>&#x02013;<lpage>135</lpage>, doi: <pub-id pub-id-type="doi">10.1016/j.fct.2014.06.007</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24952311</pub-id></mixed-citation></ref></